Standout Papers

Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults 2014 2026 2018 2022 534
  1. Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults (2014)
    Carlos A. DiazGranados, Andrew J. Dunning et al. New England Journal of Medicine

Immediate Impact

10 by Nobel laureates 11 from Science/Nature 57 standout
Sub-graph 1 of 24

Citing Papers

Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines
2023 StandoutNobel
Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery
2022 Standout
2 intermediate papers

Works of Daniel Kirby being referenced

Microfluidics based manufacture of liposomes simultaneously entrapping hydrophilic and lipophilic drugs
2016

Author Peers

Author Last Decade Papers Cites
Daniel Kirby 844 350 736 657 58 2.7k
Kevin J. McHugh 1262 388 914 686 105 4.5k
Kevin O. Kisich 700 245 639 234 23 2.4k
Ruth Prassl 1465 324 308 245 86 3.5k
You Zhou 1400 84 523 480 84 3.5k
Mark A. Suckow 1343 154 428 222 130 3.9k
Stephen C. Davis 1246 91 153 536 79 4.1k
Andrew J. Mitchell 1514 35 1330 293 76 3.9k
Nathalie Dereuddre‐Bosquet 813 108 1210 488 113 3.4k
Georgette D. Kanmogne 643 111 376 442 57 2.9k
Patrick J. Tighe 1764 40 1135 355 125 4.6k

All Works

Loading papers...

Rankless by CCL
2026